Publicaciones en colaboración con investigadores/as de University of Groningen (10)

2021

  1. Cardiovascular outcomes with sodium–glucose cotransporter-2 inhibitors vs other glucose-lowering drugs in 13 countries across three continents: analysis of CVD-REAL data

    Cardiovascular Diabetology, Vol. 20, Núm. 1

  2. Malignancies among children and young people with HIV in Western and Eastern Europe and Thailand the European Pregnancy and Paediatric Infections Cohort Collaboration (EPPICC) study group

    AIDS, Vol. 35, Núm. 12, pp. 1973-1985

2020

  1. External validation of prognostic models predicting pre-eclampsia: individual participant data meta-analysis

    BMC medicine, Vol. 18, Núm. 1, pp. 302

  2. Kidney outcomes associated with use of SGLT2 inhibitors in real-world clinical practice (CVD-REAL 3): a multinational observational cohort study

    The Lancet Diabetes and Endocrinology, Vol. 8, Núm. 1, pp. 27-35

  3. Risk of cardiovascular events and death associated with initiation of SGLT2 inhibitors compared with DPP-4 inhibitors: an analysis from the CVD-REAL 2 multinational cohort study

    The Lancet Diabetes and Endocrinology, Vol. 8, Núm. 7, pp. 606-615

  4. Validation and development of models using clinical, biochemical and ultrasound markers for predicting pre-eclampsia: An individual participant data meta-analysis

    Health Technology Assessment, Vol. 24, Núm. 72, pp. 1-290

2018

  1. Cardiovascular Events Associated With SGLT-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL 2 Study

    Journal of the American College of Cardiology, Vol. 71, Núm. 23, pp. 2628-2639

2017

  1. Recommendations for mechanical ventilation of critically ill children from the Paediatric Mechanical Ventilation Consensus Conference (PEMVECC)

    Intensive Care Medicine

2014

  1. The PedPAD study: Boys predominate in the hypogammaglobulinaemia registry of the ESID online database

    Clinical and Experimental Immunology, Vol. 176, Núm. 3, pp. 387-393

2010

  1. Revertant mosaicism due to a second-site mutation in COL7A1 in a patient with recessive dystrophic epidermolysis bullosa

    Journal of Investigative Dermatology, Vol. 130, Núm. 10, pp. 2407-2411